These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 25501870)
21. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods. Grobelny P; Kazakevich I; Zhang D; Bogner R Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240 [TBL] [Abstract][Full Text] [Related]
22. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug. Maniruzzaman M; Nair A; Renault M; Nandi U; Scoutaris N; Farnish R; Bradley MS; Snowden MJ; Douroumis D Int J Pharm; 2015 Dec; 496(1):52-62. PubMed ID: 26387621 [TBL] [Abstract][Full Text] [Related]
23. EVALUATION OF SORPTIVE PROPERTIES OF VARIOUS CARRIERS AND COATING MATERIALS FOR LIQUISOLID SYSTEMS. Vraníková B; Gajdziok J Acta Pol Pharm; 2015; 72(3):539-49. PubMed ID: 26642662 [TBL] [Abstract][Full Text] [Related]
24. Isolation and Physical Property Optimization of an Amorphous Drug Substance Utilizing a High Surface Area Magnesium Aluminometasilicate (Neusilin(®) US2). Allgeier MC; Piper JL; Hinds J; Yates MH; Kolodsick KJ; Meury R; Shaw B; Kulkarni MR; Remick DM J Pharm Sci; 2016 Oct; 105(10):3105-3114. PubMed ID: 27492963 [TBL] [Abstract][Full Text] [Related]
25. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs. Zhang P; Forsgren J; Strømme M Int J Pharm; 2014 Sep; 472(1-2):185-91. PubMed ID: 24950364 [TBL] [Abstract][Full Text] [Related]
26. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties. Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116 [TBL] [Abstract][Full Text] [Related]
27. Development of Solid SEDDS, V: Compaction and Drug Release Properties of Tablets Prepared by Adsorbing Lipid-Based Formulations onto Neusilin® US2. Gumaste SG; Dalrymple DM; Serajuddin AT Pharm Res; 2013 Jun; 30(12):3186-99. PubMed ID: 23797463 [TBL] [Abstract][Full Text] [Related]
28. Enhancement of the dissolution rate and bioavailability of fenofibrate by a melt-adsorption method using supercritical carbon dioxide. Cha KH; Cho KJ; Kim MS; Kim JS; Park HJ; Park J; Cho W; Park JS; Hwang SJ Int J Nanomedicine; 2012; 7():5565-75. PubMed ID: 23118538 [TBL] [Abstract][Full Text] [Related]
29. Mesoporous silica material TUD-1 as a drug delivery system. Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183 [TBL] [Abstract][Full Text] [Related]
30. Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestion. Kazi M; Al-Qarni H; Alanazi FK Eur J Pharm Biopharm; 2017 May; 114():239-249. PubMed ID: 28159721 [TBL] [Abstract][Full Text] [Related]
31. Impact of Porous Excipients on the Manufacturability and Product Performance of Solid Self-Emulsifying Drug Delivery Systems. Beringhs AO; Minatovicz BC; Zhang GGZ; Chaudhuri B; Lu X AAPS PharmSciTech; 2018 Oct; 19(7):3298-3310. PubMed ID: 30218264 [TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of co-grinded mixtures of aceclofenac and neusilin US2 for dissolution enhancement of aceclofenac. Vadher AH; Parikh JR; Parikh RH; Solanki AB AAPS PharmSciTech; 2009; 10(2):606-14. PubMed ID: 19444620 [TBL] [Abstract][Full Text] [Related]
33. Role of Porous Carriers in the Biopharmaceutical Performance of Solid SMEDDS of Canagliflozin. Singh D; Tiwary AK; Bedi N Recent Pat Drug Deliv Formul; 2018; 12(3):179-198. PubMed ID: 30295193 [TBL] [Abstract][Full Text] [Related]
34. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates. Hailu SA; Bogner RH J Pharm Sci; 2011 Apr; 100(4):1503-15. PubMed ID: 24081473 [TBL] [Abstract][Full Text] [Related]
35. Manufacture and performance evaluation of a stable amorphous complex of an acidic drug molecule and Neusilin. Maclean J; Medina C; Daurio D; Alvarez-Nunez F; Jona J; Munson E; Nagapudi K J Pharm Sci; 2011 Aug; 100(8):3332-3344. PubMed ID: 21520086 [TBL] [Abstract][Full Text] [Related]
36. Drug loading into porous calcium carbonate microparticles by solvent evaporation. Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926 [TBL] [Abstract][Full Text] [Related]
37. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Balakrishnan P; Lee BJ; Oh DH; Kim JO; Hong MJ; Jee JP; Kim JA; Yoo BK; Woo JS; Yong CS; Choi HG Eur J Pharm Biopharm; 2009 Aug; 72(3):539-45. PubMed ID: 19298857 [TBL] [Abstract][Full Text] [Related]
38. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
39. Nanoporous magnesium aluminometasilicate tablets for precise, controlled, and continuous dosing of chemical reagents and catalysts: applications in parallel solution-phase synthesis. Ruhland T; Nielsen SD; Holm P; Christensen CH J Comb Chem; 2007; 9(2):301-5. PubMed ID: 17348735 [TBL] [Abstract][Full Text] [Related]
40. Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents. Madieh S; Simone M; Wilson W; Mehra D; Augsburger L J Pharm Sci; 2007 Apr; 96(4):851-63. PubMed ID: 17221849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]